Associated Papers
Association between PPARγ polymorphisms and neurological functional disability of ischemic stroke.
Yan R et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 2025
Target gene variations of PPAR isoforms may contribute to MODY heterogeneity: A preliminary comparative study with type 2 diabetes.
Yilmaz-Aydogan H et al.
Diabetes Research and Clinical Practice, 2024
The Analysis of ECE1 and PPARG Variants in the Development of Osteopenia and Osteoporosis in Postmenopausal Women.
Uzar I et al.
Biomedicines, 2024
Osteoarthritis improvement effect of Chrysanthemum zawadskii var. latilobum extract in relation to genotype.
Lee T et al.
International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition, 2023
Peroxisome proliferator-activated receptor γ Pro12 ala polymorphism and risk of cerebral stroke in type 2 diabetes mellitus egyptian patients.
El-Farahaty RM et al.
Journal of Diabetes and Metabolic Disorders, 2023
The Influence of FAM13A and PPAR-γ2 Gene Polymorphisms on the Metabolic State of Postmenopausal Women.
Grygiel-Górniak B et al.
Genes, 2023
Deciphering the chromatin spatial organization landscapes during BMMSC differentiation.
Teng Z et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao, 2023
Association of the rs3856806 Polymorphism in the PPARG Gene with Type 2 Diabetes Mellitus: A Meta-Analysis of 11,811 Individuals.
Tiongco RE et al.
Laboratory Medicine, 2023
rs10865710 polymorphism in PPARG promoter is associated with the severity of type 2 diabetes mellitus and coronary artery disease in a Chinese population.
Song Y et al.
Postgraduate Medical Journal, 2022
The Correlation Between Peroxisome Proliferator-Activated Receptor Alpha and Gamma Polymorphisms and Acute Coronary Syndrome.
Kemanci A et al.
Cureus, 2022
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E et al.
Biochemical Genetics, 2022
PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease.
Song Y et al.
Frontiers in Cardiovascular Medicine, 2022
G Allele of the rs1801282 Polymorphism in PPARγ Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis.
Li S et al.
Frontiers in Endocrinology, 2022
Effects of PPARG and PPARGC1A gene polymorphisms on obesity markers.
Muntean C et al.
Frontiers in Public Health, 2022
Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study.
Unal E et al.
Biochemical Genetics, 2021
Relationship between PPAR-γ gene polymorphisms and ischemic stroke risk: A meta-analysis.
Cheng F et al.
Brain and Behavior, 2021
Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis.
Heng AHS et al.
Bmc Medical Genomics, 2021
PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China.
Su Y et al.
Clinics and Research in Hepatology and Gastroenterology, 2020
The Trp64Arg polymorphism in β3 adrenergic receptor (ADRB3) gene is associated with adipokines and plasma lipids: a systematic review, meta-analysis, and meta-regression.
Luo Z et al.
Lipids in Health and Disease, 2020
Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events.
Saki S et al.
Middle East Journal of Digestive Diseases, 2020
Association between PPARG genetic polymorphisms and ischemic stroke risk in a northern Chinese Han population: a case-control study.
Wang YZ et al.
Neural Regeneration Research, 2019
Genetic polymorphisms of PPAR genes and human cancers: evidence for gene-environment interactions.
Dhaini HR et al.
Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, 2019
The Association of Polymorphisms in Circadian Clock and Lipid Metabolism Genes With 2nd Trimester Lipid Levels and Preterm Birth.
Kovac U et al.
Frontiers in Genetics, 2019
Associations of Leptin Receptor and Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms with Polycystic Ovary Syndrome: A Meta-Analysis.
Liang J et al.
Annals of Nutrition & Metabolism, 2019
PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S et al.
Advances in Medical Sciences, 2018
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin.
Chao CT et al.
Nephrology (carlton, Vic.), 2018
PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis.
Ding H et al.
Oncotarget, 2017
Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-activated Receptor γ2 Gene on Lipid Profile and Adipokines Levels in Obese Subjects.
Becer E et al.
Balkan Journal of Medical Genetics : Bjmg, 2017
Association between peroxisome proliferator-activated receptor γ gene polymorphism and susceptibility to northwest dryness syndrome.
Wang Y et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan, 2017
[Correlation between CYP2C19 Gene Polymorphism with Clopidogrel Resistance and Distribution of Chinese Medicine Syndrome in 229 Acute Coronary Syndrome Patients].
Shen ZJ et al.
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine, 2017
Associations between PPARG polymorphisms and the risk of essential hypertension.
Cai G et al.
Plos One, 2017
Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y et al.
Medicine, 2016
Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation.
Corsetti JP et al.
Atherosclerosis, 2016
Correlations Between Leptin Gene Polymorphisms 223 A/G, 1019 G/A, 492 G/C, 976 C/A, and Anthropometrical and Biochemical Parameters in Children With Obesity: A Prospective Case-Control Study in a Romanian Population-The Nutrichild Study.
Mărginean CO et al.
Medicine, 2016
Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients.
Chao CT et al.
Oxidative Medicine and Cellular Longevity, 2016
Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study.
Simons CC et al.
Scientific Reports, 2015
A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis.
Marangoni RG et al.
Arthritis Research & Therapy, 2015
Association of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies.
Li Q et al.
Journal of Cellular and Molecular Medicine, 2015
Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease.
Chao CT et al.
Disease Markers, 2015
Association between Peroxisome Proliferator-activated Receptor Gamma Gene Polymorphisms and Atherosclerotic Diseases: A Meta-analysis of Case-control Studies.
Wang P et al.
Journal of Atherosclerosis and Thrombosis, 2015
Impact of the C1431T Polymorphism of the Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ) Gene on Fasted Serum Lipid Levels in Patients with Coronary Artery Disease.
Oladi M et al.
Annals of Nutrition & Metabolism, 2015
Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms and gene-gene interaction with asthma risk in a Chinese adults population.
Li W et al.
International Journal of Clinical and Experimental Medicine, 2015
Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.
Chehaibi K et al.
Journal of Molecular Neuroscience : Mn, 2014
Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients.
Liu F et al.
Molecular Biology Reports, 2014
Peroxisome proliferator‑activated receptor γ polymorphisms as risk factors for dyslipidemia.
Gu SJ et al.
Molecular Medicine Reports, 2014
[Association between apolipoprotein A1-75 bp gene polymorphisms and risk for dyslipidemia and coronary artery disease].
Wei X et al.
Zhonghua Xin Xue Guan Bing Za Zhi, 2014
Association of cholesteryl ester transfer protein (CETP) gene polymorphism, high density lipoprotein cholesterol and risk of coronary artery disease: a meta-analysis using a Mendelian randomization approach.
Wu Z et al.
Bmc Medical Genetics, 2014
Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population.
Rooki H et al.
Molecular Biology Reports, 2014
Combined effects of the C161T and Pro12Ala PPARγ2 gene variants with insulin resistance on metabolic syndrome: a case-control study of a central Tunisian population.
Youssef SM et al.
Journal of Molecular Neuroscience : Mn, 2014